Interim analysis of NCT02458716: Feasibility of cytoreductive prostatectomy in men newly diagnosed with metastatic prostate cancer.

被引:0
|
作者
Yuh, Bertram E.
Kwon, Young Suk
Shinder, Brian
Kim, Sinae
Lee, Nara
Ruel, Nora
机构
关键词
D O I
10.1200/JCO.2017.35.6_suppl.e578
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e578
引用
收藏
页数:2
相关论文
共 50 条
  • [31] INTERIM RESULTS ON A RANDOMIZED TRIAL OF MITOMYCIN-C IN COMBINATION WITH ORCHIECTOMY FOR NEWLY-DIAGNOSED METASTATIC PROSTATE-CANCER
    VANDENBROUCKE, F
    VANPOPPEL, H
    DERLUYN, J
    POPELIER, G
    CASSELMAN, J
    BILLIET, I
    VANUYTSEL, L
    PARIDAENS, R
    BAERT, L
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (03): : 263 - 266
  • [32] LONG-TERM RESULTS OF CYTOREDUCTIVE RADICAL PROSTATECTOMY IN MEN WITH HORMONE-NAIVE, LOW VOLUME METASTATIC PROSTATE CANCER(MHNPCA)
    John, Patricia
    Pfister, David
    Heidenreich, Axel
    Hartmann, Florian
    JOURNAL OF UROLOGY, 2020, 203 : E1221 - E1222
  • [33] Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm H
    Sophie Knipper
    Burkhard Beyer
    Philipp Mandel
    Pierre Tennstedt
    Derya Tilki
    Thomas Steuber
    Markus Graefen
    World Journal of Urology, 2020, 38 : 1459 - 1464
  • [34] Outcome of patients with newly diagnosed prostate cancer with low metastatic burden treated with radical prostatectomy: a comparison to STAMPEDE arm H
    Knipper, Sophie
    Beyer, Burkhard
    Mandel, Philipp
    Tennstedt, Pierre
    Tilki, Derya
    Steuber, Thomas
    Graefen, Markus
    WORLD JOURNAL OF UROLOGY, 2020, 38 (06) : 1459 - 1464
  • [35] INTERIM ANALYSIS OF PHASE 2 RANDOMIZED PROSPECTIVE STUDY ON NEOADJUVANT APALUTAMIDE/ABIRATERONE ACETATE WITH PREDNISONE AND THE FEASIBILITY OF PERFORMING NERVE-SPARING RADICAL PROSTATECTOMY IN MEN WITH HIGH-RISK PROSTATE CANCER (NCT02949284)
    Sterling, Joshua
    Chua, Kevin
    Patel, Hiren
    Kim, Isaac
    JOURNAL OF UROLOGY, 2020, 203 : E249 - E249
  • [36] The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: A population based analysis
    Albertsen, PC
    Hanley, JA
    Harlan, LC
    Gilliland, FD
    Hamilton, A
    Liff, JM
    Stanford, JL
    Stephenson, RA
    JOURNAL OF UROLOGY, 2000, 163 (04): : 1138 - 1143
  • [37] A multidisciplinary clinic to mitigate the toxicity of therapy for newly diagnosed metastatic prostate cancer undergoing chemohormonal therapy: A feasibility study.
    Hough, Jeffrey
    Rodvelt, Tammy J.
    Thomas, Miles
    Ma, Brian
    Rabow, Michael W.
    Weinberg, Rami
    Macaire, Greta
    Shepard, Nancy
    Chan, June M.
    Van Blarigan, Erin
    Choque-Gonzales, Gonzalo
    Lee, Mina
    Friedlander, Terence W.
    Kim, Won
    Ryan, Charles J.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05)
  • [38] Survival with newly diagnosed metastatic prostate cancer in the "docetaxel era": Data from >600 patients in the control arm of the STAMPEDE trial (NCT00268476)
    Clarke, Noel W.
    James, Nicholas David
    Mason, Malcolm David
    Aebersold, Daniel M.
    Dearnaley, David Paul
    De Bono, Johann Sebastian
    Parker, Chris
    Parmar, Mahesh
    Ritchie, Alastair W. S.
    Russell, J. Martin
    Spears, Melissa Ruth
    Thalmann, George N.
    Sydes, Matthew Robert
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Cytoreductive radical prostatectomy versus systemic therapy and radiation therapy in metastatic prostate cancer: A systematic review and meta-analysis
    Shemshaki, Hamidreza
    Al-Mamari, Said Abdallah
    Geelani, Ishfaq Ahmed
    Kumar, Santosh
    UROLOGIA JOURNAL, 2022, 89 (01) : 16 - 30
  • [40] Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancer
    Heesterman, Berdine L.
    van der Poel, Henk G.
    Schoots, Ivo G.
    Mehra, Niven
    Aben, Katja K. H.
    BJU INTERNATIONAL, 2022, 130 (02) : 217 - 225